Aptose Biosciences
APTO
#10464
Rank
ยฃ3.27 M
Marketcap
ยฃ1.28
Share price
0.00%
Change (1 day)
718.09%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -ยฃ5.55 Million

According to Aptose Biosciences's latest financial reports the company has -ยฃ5.55 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-ยฃ2.28 Million-107.3%
2022-12-31$ยฃ31.19 M-43.28%
2021-12-31$ยฃ54.99 M-36.96%
2020-12-31$ยฃ87.24 M21.8%
2019-12-31$ยฃ71.62 M545.7%
2018-12-31$ยฃ11.09 M46.95%
2017-12-31$ยฃ7.54 M27.11%
2016-12-31$ยฃ5.93 M-35.53%
2015-12-31$ยฃ9.21 M
2014-05-31$ยฃ15.62 M-3237.23%
2013-05-31$-ยฃ0.5 Million-61.03%
2012-05-31$-ยฃ1.28 Million-960.2%
2011-05-31$ยฃ0.14 M-142.43%
2010-05-31$-ยฃ0.36 Million-92.48%
2009-05-31$-ยฃ4.66 Million138.35%
2008-05-31$-ยฃ1.96 Million-644.39%
2007-05-31$ยฃ0.35 M-128.87%
2006-05-31$-ยฃ1.25 Million-121.29%
2005-05-31$ยฃ5.84 M-48.79%
2004-05-31$ยฃ11.4 M-10.48%
2003-05-31$ยฃ12.74 M-35.39%
2002-05-31$ยฃ19.71 M-22.75%
2001-05-31$ยฃ25.52 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-ยฃ18.33 Million 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
ยฃ83.29 M-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
ยฃ0.42 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA